UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 29.

Schroeder, Clemens; Park, Min Tae M; Germann, Jürgen; Chakravarty, Mallar M; Michels, Lars; Kollias, Spyros; Kroll, Sara; Buck, Alfred; Treyer, Valerie; Savaskan, E; Unschuld, Paul G; Nitsch, Roger M; Kälin, Andrea M; Hock, Christoph; Gietl, Anton F; Leh, Sandra E (2017). Hippocampal shape alterations are associated with regional Aβ load in cognitively normal elderly individuals. European Journal of Neuroscience, 45(10):1241-1251.

Savaskan, E (2015). Schlafstörungen bei Demenzkranken. Zeitschrift für Gerontologie und Geriatrie, 48(4):312-317.

Savaskan, E (2012). Delir und Multimorbidität im Alter. Praxis, 101(25):1633-1636.

Savaskan, E. Altersdepressionen - Besonderheiten und Aussichten. 2011, University of Zurich, Faculty of Medicine.

Savaskan, E. Venia Legendi für das Gebiet Psychiatrie. 2010, University of Zurich, Faculty of Medicine.

Savaskan, E (2010). Das emotionale Gedächtnis im Alter und bei Depression. Praxis, 99(25):1565-1568.

Savaskan, E (2010). Demenzen: Epidemiologie, klinsches Bild und differenzialdiagnostische Abklärungen. INFO Neurologie & Psychiatrie, 8(1):8-10.

Wirz-Justice, A; Schröder, C M; Gasio, P F; Cajochen, C; Savaskan, E (2010). The circadian rest-activity cycle in korsakoff psychosis. American Journal of Geriatric Psychiatry, 18(1):33-41.

Rhein, V; Song, X; Wiesner, A; Ittner, L M; Baysang, G; Meier, F; Ozmen, L; Bluethmann, H; Dröse, S; Brandt, U; Savaskan, E; Czech, C; Götz, J; Eckert, A (2009). Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 106(47):20057-20062.

Schachinger, H; Blumenthal, T D; Richter, S; Savaskan, E; Wirz-Justice, A; Kräuchi, K (2008). Melatonin reduces arousal and startle responsiveness without influencing startle habituation or affective startle modulation in young women. Hormones and Behavior, 54(2):258-262.

Savaskan, E (2008). Aktuelle Therapien der Demenzen und Zukunftsaussichten. In: Stalder, P B. Vortragszyklus zum dritten Lebensabschnitt / Band 2 Themenkreis: "Zu Hause alt werden". Basel, CH: Reinhardt, ?-?.

Savaskan, E; Müller, S E; Böhringer, A; Schulz-Baldes, A; Schächinger, H (2008). Antidepressive therapy with escitalopram improves mood, cognitive symptoms, and identity memory for angry faces in elderly depressed patients. International Journal of Neuropsychopharmacology, 11(3):381-8.

Savaskan, E; Ehrhardt, R; Schulz-Baldes, A; Walter, M; Schächinger, H (2008). Post-learning intranasal oxytocin modulates human memory for facial identity. Psychoneuroendocrinology, 33(3):368-374.

Savaskan, E; Müller, S E; Böhringer, A; Philippsen, C; Müller-Spahn, F; Schächinger, H (2007). Age determines memory for face identity and expression. Psychogeriatrics, 7(2):49-57.

Hamouda, H O; Chen, P; Levoye, A; Sözer-Topçular, N; Daulat, A M; Guillaume, J L; Ravid, R; Savaskan, E; Ferry, G; Boutin, J A; Delagrange, P; Jockers, R; Maurice, P (2007). Detection of the human GPR50 orphan seven transmembrane protein by polyclonal antibodies mapping different epitopes. Journal of Pineal Research, 43(1):10-15.

Walter, M; Hänni, B; Haug, M; Amrhein, I; Krebs-Roubicek, E; Müller-Spahn, F; Savaskan, E (2007). Humour therapy in patients with late-life depression or Alzheimer's disease: a pilot study. International Journal of Geriatric Psychiatry, 22(1):77-83.

Savaskan, E; Jockers, R; Ayoub, M; Angeloni, D; Fraschini, F; Flammer, J; Eckert, A; Müller-Spahn, F; Meyer, P (2007). The MT2 melatonin receptor subtype is present in human retina and decreases in Alzheimer's disease. Current Alzheimer Research, 4(1):47-51.

Levoye, A; Jockers, R; Ayoub, M A; Delagrange, P; Savaskan, E; Guillaume, J L (2006). Are G protein-coupled receptor heterodimers of physiological relevance?--Focus on melatonin receptors. Chronobiology International, 23(1-2):419-426.

Brunner, P; Sözer-Topcular, N; Jockers, R; Ravid, R; Angeloni, D; Fraschini, F; Eckert, A; Müller-Spahn, F; Savaskan, E (2006). Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease. European Journal of Histochemistry, 50(4):311-316.

Savaskan, E; Schnitzler, C; Schröder, C; Cajochen, C; Müller-Spahn, F; Wirz-Justice, A (2006). Treatment of behavioural, cognitive and circadian rest-activity cycle disturbances in Alzheimer's disease: haloperidol vs. quetiapine. International Journal of Neuropsychopharmacology, 9(5):507-516.

Savaskan, E; Ravid, R; Meier, F; Müller-Spahn, F; Jockers, R (2005). Immunohistochemical localization of fas-associated phosphatase-1 (FAP-1) in Alzheimer disease hippocampus. Applied Immunohistochemistry & Molecular Morphology, 13(2):190-193.

Savaskan, E; Ayoub, M A; Ravid, R; Angeloni, D; Fraschini, F; Meier, F; Eckert, A; Müller-Spahn, F; Jockers, R (2005). Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease. Journal of Pineal Research, 38(1):10-16.

Savaskan, E; Löffler, K U; Meier, F; Müller-Spahn, F; Flammer, J; Meyer, P (2004). Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II and AT1 receptor in human ocular tissues. Ophthalmic Research, 36(6):312-320.

Savaskan, E; Müller-Spahn, F; Meier, F; Wirz-Justice, A; Meyer, P (2004). Orexins and their receptors in the human retina. Pathobiology, 71(4):211-216.

Olivieri, G; Otten, U; Meier, F; Baysang, G; Dimitriades-Schmutz, B; Müller-Spahn, F; Savaskan, E (2003). Beta-amyloid modulates tyrosine kinase B receptor expression in SHSY5Y neuroblastoma cells: influence of the antioxidant melatonin. Neuroscience, 120(3):659-665.

Pache, M; Smeets, C H W; Gasio, P F; Savaskan, E; Flammer, J; Wirz-Justice, A; Kaiser, H J (2003). Colour vision deficiencies in Alzheimer's disease. Age and Ageing, 32(4):422-426.

Fontana Gasio, P; Kräuchi, K; Cajochen, C; van Someren, E; Amrhein, I; Pache, M; Savaskan, E; Wirz-Justice, A (2003). Dawn-dusk simulation light therapy of disturbed circadian rest-activity cycles in demented elderly. Experimental Gerontology, 38(1-2):207-216.

Savaskan, E; Olivieri, G; Meier, F; Seifritz, E; Wirz-Justice, A; Müller-Spahn, F (2003). Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity. Gerontology, 49(6):380-383.

Rösler, A; Seifritz, E; Kräuchi, K; Spoerl, D; Brokuslaus, I; Proserpi, S M; Gendre, A; Savaskan, E; Hofmann, M (2002). Skill learning in patients with moderate Alzheimer's disease: a prospective pilot-study of waltz-lessons. International Journal of Geriatric Psychiatry, 17(12):1155-1156.

This list was generated on Mon Jul 24 09:00:46 2017 CEST.